Letters A/H1N1 flu

Policy on antiviral drugs needs to be revised …

BMJ 2009; 339 doi: http://dx.doi.org/10.1136/bmj.b2728 (Published 08 July 2009) Cite this as: BMJ 2009;339:b2728
  1. Peter M English, business secretary1,
  2. Kevin Carroll, general practitioner2,
  3. Azeem Majeed, professor of primary care3,
  4. Torbjorn Sundkvist, consultant in infectious diseases4,
  5. Sally Millership, president5,
  6. Sharon Chambers, consultant microbiologist6
  1. 1Public Health Medicine Environment Group, c/o Dorset House, Leatherhead KT22 7PL
  2. 2Hackbridge, Wallington, Surrey
  3. 3Imperial College London
  4. 4Suffolk
  5. 5Public Health Medicine Environment Group, c/o Collingwood Road, Witham, Essex CM8 2TT
  6. 6Microbiology Laboratory, Epsom, Surrey KT19 8BP
  1. petermbenglish{at}gmail.com

    UK swine flu policy recommends antiviral agents for febrile patients with two or more symptoms of flu-like illness, up to seven days from onset.1 Thus, even with comparatively low rates of flu-like illness, many people are prescribed antiviral agents. We lack a clear evidence base that this policy is effective in clinical, public health, and economic terms, and that we are …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial